What is the dosing regimen for Rocephin (ceftriaxone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rocephin (Ceftriaxone) Dosing Guidelines

For most adult infections, ceftriaxone is dosed at 1-2 grams IV or IM once daily, though serious central nervous system infections require 2 grams IV every 12 hours to ensure adequate tissue penetration throughout the dosing interval. 1, 2

Standard Adult Dosing by Indication

Uncomplicated Infections

  • Uncomplicated gonococcal infections: 250 mg IM as a single dose 1, 2
  • Skin and soft tissue infections: 1 gram every 12-24 hours depending on severity 1
  • Urinary tract infections: 1 gram IM/IV once daily 1

Serious Infections Requiring Higher/More Frequent Dosing

Central Nervous System Infections (requires twice-daily dosing):

  • Bacterial meningitis: 2 grams IV every 12 hours (total 4 grams daily) for 10-14 days 1, 2
  • Pneumococcal meningitis: 2 grams IV every 12 hours for 10-14 days, extending treatment if clinical response is delayed 1
  • Meningococcal meningitis: 2 grams IV every 12 hours for 5 days 1
  • Gonococcal meningitis: 1-2 grams IV every 12 hours for 10-14 days 1

The twice-daily dosing for meningitis is critical during the first 24 hours to achieve rapid CSF sterilization; once-daily dosing may be considered only for stable patients after this period. 1

Endocarditis:

  • HACEK organisms: 2 grams IV/IM once daily for 4 weeks (6 weeks for prosthetic valve) 3, 1
  • Highly penicillin-susceptible viridans streptococci (MIC ≤0.12 μg/mL): 2 grams IV/IM once daily for 4 weeks as monotherapy 1
  • Gonococcal endocarditis: 1-2 grams IV every 12 hours for at least 4 weeks 1

Disseminated Gonococcal Infection (DGI):

  • 1 gram IM or IV every 24 hours initially, continuing for 24-48 hours after clinical improvement, then switch to oral therapy to complete one week total 1

Maximum Daily Dose

The total daily dose should not exceed 4 grams in adults. 2

Pediatric Dosing

Neonates

  • Age ≤7 days: 50 mg/kg/day given every 24 hours 4
  • Age >7 days and ≤2000 g: 50 mg/kg/day given every 24 hours 4
  • Age >7 days and >2000 g: 50-75 mg/kg/day given every 24 hours 4
  • Neonatal gonococcal infections: 25-50 mg/kg/day IV or IM once daily for 7 days (10-14 days if meningitis documented) 1

Critical contraindication: Ceftriaxone is contraindicated in hyperbilirubinemic neonates and premature infants, and in neonates ≤28 days requiring calcium-containing IV solutions. 4, 2

Infants and Children

  • General infections: 50-75 mg/kg/day divided every 12-24 hours (maximum 2 grams daily) 4, 2
  • Meningitis: Initial dose 100 mg/kg (not to exceed 4 grams), then 100 mg/kg/day (maximum 4 grams daily) given once daily or divided every 12 hours for 7-14 days 2
  • Acute otitis media: Single IM dose of 50 mg/kg (not to exceed 1 gram) 2
  • Children ≥45 kg: Use adult dosing regimens 1

Pediatric doses should never exceed adult dosing even when weight-based calculations suggest higher amounts. 1

Special Populations and Considerations

Elderly Patients

No dosage adjustment necessary up to 2 grams per day, provided there is no severe renal and hepatic impairment. 2

Renal/Hepatic Impairment

No dosage adjustment necessary for isolated renal or hepatic dysfunction with doses up to 2 grams daily. 2, 5 Adjustment may be needed only with combined severe hepatic and renal dysfunction. 2

Patients ≥60 Years with Suspected Meningitis

Add amoxicillin 2 grams IV every 4 hours to ceftriaxone 2 grams every 12 hours to cover Listeria monocytogenes. 1

Penicillin-Resistant Pneumococci

Add vancomycin 15-20 mg/kg IV (targeting trough levels of 15-20 mg/mL) or rifampicin 600 mg twice daily to the ceftriaxone regimen. 1

Administration Guidelines

Intravenous

  • Administer by infusion over 30 minutes for adults 2
  • Neonates require 60-minute infusion to reduce risk of bilirubin encephalopathy 2
  • Recommended concentrations: 10-40 mg/mL 2

Intramuscular

  • Inject well within the body of a relatively large muscle 2
  • Patients should be informed that IM injection is painful 3
  • Completely absorbed after IM administration with bioequivalence to IV route by 2.5 hours 6

Critical Pitfalls to Avoid

  1. Never use calcium-containing diluents (Ringer's solution, Hartmann's solution) as particulate formation can result 2
  2. Do not use in neonates receiving calcium-containing IV solutions due to risk of fatal ceftriaxone-calcium precipitation 2
  3. Avoid underdosing CNS infections: Once-daily dosing is insufficient for meningitis and other CNS infections during initial therapy 1
  4. Treatment failures documented with 250-500 mg doses for pharyngeal gonorrhea with elevated MICs; higher doses required 1
  5. Always add antichlamydial coverage for gonococcal infections if Chlamydia trachomatis not ruled out 1, 2

Duration of Therapy

Generally continue for at least 2 days after signs and symptoms of infection have disappeared, with usual duration 4-14 days depending on infection type. 2 For Streptococcus pyogenes infections, continue for at least 10 days. 2

References

Guideline

Ceftriaxone Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ceftriaxone Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetic profile of ceftriaxone in man.

The American journal of medicine, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.